The question for all of this is: What is the demand like? Has Joe been able to line up buyers for these NGIO and NGIOP shares, or will it take a new catalyst like a CV vaccine to bring people in and to support shares after they hit the market?
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links